-
Something wrong with this record ?
Myeloperoxidase Deficiency Alters the Process of the Regulated Cell Death of Polymorphonuclear Neutrophils
S. Kremserová, A. Kocurková, M. Chorvátová, A. Klinke, L. Kubala
Language English Country Switzerland
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2010
Free Medical Journals
from 2010
PubMed Central
from 2010
Europe PubMed Central
from 2010
Open Access Digital Library
from 2010-01-01
Open Access Digital Library
from 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
- MeSH
- Mice, Inbred C57BL MeSH
- Mice MeSH
- Neutrophils metabolism pathology MeSH
- Peroxidase deficiency metabolism MeSH
- Regulated Cell Death MeSH
- Inflammation metabolism MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Polymorphonuclear neutrophils (PMNs) play a key role in host defense. However, their massive accumulation at the site of inflammation can delay regenerative healing processes and can initiate pathological inflammatory processes. Thus, the efficient clearance of PMNs mediated by the induction of regulated cell death is a key process preventing the development of these pathological conditions. Myeloperoxidase (MPO), a highly abundant enzyme in PMN granules, primarily connected with PMN defense machinery, is suggested to play a role in PMN-regulated cell death. However, the contribution of MPO to the mechanisms of PMN cell death remains incompletely characterized. Herein, the process of the cell death of mouse PMNs induced by three different stimuli - phorbol 12-myristate 13-acetate (PMA), opsonized streptococcus (OST), and N-formyl-met-leu-phe (fMLP) - was investigated. MPO-deficient PMNs revealed a significantly decreased rate of cell death characterized by phosphatidylserine surface exposure and cell membrane permeabilization. An inhibitor of MPO activity, 4-aminobenzoic acid hydrazide, did not exhibit a significant effect on PMA-induced cell death compared to MPO deficiency. Interestingly, only the limited activation of markers related to apoptotic cell death was observed (e.g. caspase 8 activation, Bax expression) and they mostly did not correspond to phosphatidylserine surface exposure. Furthermore, a marker characterizing autophagy, cleavage of LC3 protein, as well as histone H3 citrullination and its surface expression was observed. Collectively, the data show the ability of MPO to modulate the life span of PMNs primarily through the potentiation of cell membrane permeabilization and phosphatidylserine surface exposure.
Department of Experimental Biology Faculty of Science Masaryk University Brno Czechia
Institute of Biophysics Academy of Sciences of the Czech Republic Brno Czechia
International Clinical Research Center St Anne's University Hospital Brno Brno Czechia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011044
- 003
- CZ-PrNML
- 005
- 20220506131113.0
- 007
- ta
- 008
- 220425s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fimmu.2022.707085 $2 doi
- 035 __
- $a (PubMed)35211113
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kremserová, Silvie $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czechia
- 245 10
- $a Myeloperoxidase Deficiency Alters the Process of the Regulated Cell Death of Polymorphonuclear Neutrophils / $c S. Kremserová, A. Kocurková, M. Chorvátová, A. Klinke, L. Kubala
- 520 9_
- $a Polymorphonuclear neutrophils (PMNs) play a key role in host defense. However, their massive accumulation at the site of inflammation can delay regenerative healing processes and can initiate pathological inflammatory processes. Thus, the efficient clearance of PMNs mediated by the induction of regulated cell death is a key process preventing the development of these pathological conditions. Myeloperoxidase (MPO), a highly abundant enzyme in PMN granules, primarily connected with PMN defense machinery, is suggested to play a role in PMN-regulated cell death. However, the contribution of MPO to the mechanisms of PMN cell death remains incompletely characterized. Herein, the process of the cell death of mouse PMNs induced by three different stimuli - phorbol 12-myristate 13-acetate (PMA), opsonized streptococcus (OST), and N-formyl-met-leu-phe (fMLP) - was investigated. MPO-deficient PMNs revealed a significantly decreased rate of cell death characterized by phosphatidylserine surface exposure and cell membrane permeabilization. An inhibitor of MPO activity, 4-aminobenzoic acid hydrazide, did not exhibit a significant effect on PMA-induced cell death compared to MPO deficiency. Interestingly, only the limited activation of markers related to apoptotic cell death was observed (e.g. caspase 8 activation, Bax expression) and they mostly did not correspond to phosphatidylserine surface exposure. Furthermore, a marker characterizing autophagy, cleavage of LC3 protein, as well as histone H3 citrullination and its surface expression was observed. Collectively, the data show the ability of MPO to modulate the life span of PMNs primarily through the potentiation of cell membrane permeabilization and phosphatidylserine surface exposure.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a zánět $x metabolismus $7 D007249
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a neutrofily $x metabolismus $x patologie $7 D009504
- 650 _2
- $a peroxidasa $x nedostatek $x metabolismus $7 D009195
- 650 _2
- $a regulovaná buněčná smrt $7 D000079404
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kocurková, Anna $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czechia $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia
- 700 1_
- $a Chorvátová, Michaela $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czechia $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia
- 700 1_
- $a Klinke, Anna $u Clinic of General and Interventional Cardiology/Angiology, Agnes Wittenborg Institute of Translational Cardiovascular Research, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany
- 700 1_
- $a Kubala, Lukáš $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czechia $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia
- 773 0_
- $w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 13, č. - (2022), s. 707085
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35211113 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131106 $b ABA008
- 999 __
- $a ok $b bmc $g 1788905 $s 1162242
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 13 $c - $d 707085 $e 20220208 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
- LZP __
- $a Pubmed-20220425